Terminated PHASE3 INTERVENTIONAL 2-arm NCT00032084

S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

Smoking Cessation Intervention (Including Bupropion-Zyban Versus Placebo) for Completely Resected Stage I and II Non-Small Cell Lung Cancer Survivors Who Are Current Smokers

Sponsor: Cancer and Leukemia Group B

Conditions Lung Cancer

Interventions bupropion hydrochloride nicotine psychosocial assessment and care smoking cessation intervention

Updated 8 times since 2017 Last updated: Mar 8, 2013 Started: Jan 31, 2002 Primary completion: Feb 29, 2004 Completion: Feb 29, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This study was closed early due to poor accrual

Other terminated trials from Cancer and Leukemia Group B

See all terminations from Cancer and Leukemia Group B

Other Lung Cancer trials with similar outcome

Browse all Lung Cancer trials

Listed as NCT00032084, this PHASE3 trial focuses on Lung Cancer and remains terminated or withdrawn. Sponsored by Cancer and Leukemia Group B, it has been updated 8 times since 2002, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
May 2023 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — May 2023 [monthly]

Terminated PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cancer and Leukemia Group B
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
SWOG Cancer Research Network

Data source: SWOG Cancer Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Albuquerque, United States , Amarillo, United States , Ann Arbor, United States , Anniston, United States , Asheville, United States , Atlanta, United States , Baltimore, United States , Bennington, United States , Billings, United States and 107 more locations